Daily non-political popular news in brief.
New adjuvant treatments for breast cancer prove cost-effective
06-25-2007 · EurekAlert!New adjuvant treatments for breast cancer are cost-effective at improving survival, according to two new studies.
Read more »
Keywords: adjuvant, treatments, breast, cancer, prove, cost-effective, treatment, cost, effective
« Previous | Next »
Similar news on "New adjuvant treatments for breast cancer prove cost-effective":
- Cost-benefit analysis: Combo treatment costs more, saves money later
11-07-2006 · EurekAlert!
From a health insurer's perspective, the most effective cancer treatment may also be the most cost-effective, according to a new study sponsored by the Radiation Therapy Oncology Group (RTOG 91-11). Compared to higher-priced combination treatments, the least expensive, single-modality cancer treatment may cost more in the long run because of the costs associated with treating complications and recurrence of cancer.
Similar news · Read more »
- Study offers innovative profile of enzyme that aids tumor growth
10-20-2006 · EurekAlert!
Using an innovative profiling strategy, scientists at the Scripps Research Institute have characterized an enzyme that is "highly elevated" in aggressive human tumor cells. When the enzyme, KIAA1363, was inactivated, it impaired tumor growth and migration in both ovarian and breast cancer cells, suggesting that inhibitors of this enzyme may prove valuable in the treatment of multiple types of cancer.
Similar news · Read more »
- Researchers identify key gene that may be a marker of breast cancer metastasis
04-18-2007 · EurekAlert!
Researchers at Fox Chase Cancer Center have identified an important gene involved in the spread of breast cancer that has developed resistance to long-term estrogen deprivation. The gene may prove to be a useful marker for predicting which patients have the greatest risk of breast cancer recurrence so their doctors can offer the most appropriate treatment plan.
Similar news · Read more »
- Probe to detect spread of breast cancer co-developed by UH scientist
03-06-2007 · EurekAlert!
High-temperature superconductors hold the key to a handheld tool for surgeons that promises to be more accurate, cost-effective and safer than existing methods for staging and treating various cancers, including breast cancer. Researchers at University of Houston and University College of London have developed a novel detection procedure, combining nanotechnology and advanced magnetic sensing based on high-temperature superconductors, enabling surgeons to more effectively locate the sentinel lymph node.
Similar news · Read more »
- Herceptin does not increase heart failure in patients long-term
06-03-2007 · EurekAlert!
Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
Similar news · Read more »
- A new target for the treatment of breast cancer
01-11-2007 · EurekAlert!
The active ingredient in a drug currently being tested to treat rheumatoid arthritis might also one day serve as an effective means of treating one of the deadliest forms of breast cancer. Berkeley Lab researchers have demonstrated that inhibiting the activity of the protease enzyme known as TACE can deprive tumor cells of a key factor needed for their proliferation. TACE is strongly present in a form of breast cancer which responds poorly to current therapies.
Similar news · Read more »
- Herceptin does not increase heart failure in patients long term
06-03-2007 · EurekAlert!
Risk of congestive heart failure in women treated with trastuzumab and combination chemotherapy for early stage breast cancer did not increase over time according to a five-year follow up of National Surgical Adjuvant Breast and Bowel Project trial B-31 led by the University of Pittsburgh School of Medicine. Based on the findings, the research team developed a prediction model to help oncologists assess the risk of heart failure in individual breast cancer patients prior to treatment with Herceptin and chemotherapy.
Similar news · Read more »
- Cancer conflict with chemotherapy treatment
10-10-2007 · EurekAlert!
Women under the age of 40 with breast cancer who are given drugs in addition to lumpectomies or radiotherapy, known as adjuvant chemotherapy, may not be benefiting from these drugs. This is especially true if their tumors respond to changing levels of hormones such as estrogen, according to research published in the online journal, Breast Cancer Research.
Similar news · Read more »
- High-dose chemo and stem cell transplant shows little or no survival benefit for breast cancer
12-13-2007 · EurekAlert!
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at the University of Texas M. D. Anderson Cancer Center.
Similar news · Read more »
- New radiation technique can greatly reduce painful skin burns in women with breast cancer
11-06-2006 · EurekAlert!
Breast cancer patients who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin reactions from the treatment compared to standard radiation therapy, according to a study presented at the plenary session November 6, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia. The study is the first of its kind to show how recent dramatic improvements in radiation treatments directly benefit patients.
Similar news · Read more »
